Denosumab: an investigational drug for the management of postmenopausal osteoporosis

E Michael LewieckiNew Mexico Clinical Research & Osteoporosis Center, Albuquerque, New Mexico, USAAbstract: Denosumab (AMG 162) is an investigational fully human monoclonal antibody with a high affinity and specificity for receptor activator of nuclear factor-κB ligand (RAN...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: E Michael Lewiecki
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://doaj.org/article/8bc7daaabf8d46a99e2ef8cf5c1cd09a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!